ArticleBlood advances2022
Cost-effectiveness analysis of alternative anticoagulation in suspected heparin-induced thrombocytopenia.
Aleksandra Tuleja et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it